(DCT): Johnson Fistel Investigates Proposed Sale of Duck Creek; Are Shareholders Getting a Fair Deal?


SAN DIEGO, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of Duck Creek Technologies (NASDAQ: DCT) breached their fiduciary duties in connection with the proposed sale of the Company to Vista Equity Partners (“Vista”).

On January 9, 2023, Duck Creek announced it will be acquired by private equity firm Vista in an all-cash transaction. Under the agreement terms, Duck Creek shareholders will receive only $19 per share.

You can click or copy and paste the following link to join this investigation:

https://www.cognitoforms.com/JohnsonFistel/DuckCreekTechnologies

The investigation concerns whether the Duck Creek board failed to satisfy its duties to the Company shareholders, including whether the board adequately pursued alternatives to the acquisition and whether the board obtained the best price possible for Duck Creek shares of common stock. Nationally recognized, Johnson Fistel is investigating whether the proposed deal represents adequate consideration, especially given one Wall Street analyst had a $22.00 price target on the stock. Additionally, Duck Creek just went public in 2020 at $27.00 a share and since going public the stock’s high was $58.83.

If you are a shareholder of Duck Creek and believe the proposed buyout price is too low or you're interested in learning more about the investigation, please contact lead analyst Jim Baker (jimb@johnsonfistel.com) at 619-814-4471. If emailing, please include a phone number.

About Johnson Fistel, LLP:
Johnson Fistel, LLP is a nationally recognized shareholder rights law firm with offices in California, New York, and Georgia. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. For more information about the firm and its attorneys, please visit https://www.johnsonfistel.com. Attorney advertising. Past results do not guarantee future outcomes.

Contact:
Johnson Fistel, LLP
Jim Baker, 619-814-4471
jimb@johnsonfistel.com